These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 1716719)
1. Neisseria gonorrhoeae LPS variation, serum resistance and its induction by cytidine 5'-monophospho-N-acetylneuraminic acid. Demarco de Hormaeche R; van Crevel R; Hormaeche CE Microb Pathog; 1991 Apr; 10(4):323-32. PubMed ID: 1716719 [TBL] [Abstract][Full Text] [Related]
2. Sialylation of lipopolysaccharide and loss of absorption of bactericidal antibody during conversion of gonococci to serum resistance by cytidine 5'-monophospho-N-acetyl neuraminic acid. Parsons NJ; Andrade JR; Patel PV; Cole JA; Smith H Microb Pathog; 1989 Jul; 7(1):63-72. PubMed ID: 2509853 [TBL] [Abstract][Full Text] [Related]
4. Kinetics of conversion of Neisseria gonorrhoeae to resistance to complement by cytidine 5'-monophospho-N-acetyl neuraminic acid. Emond JP; Dublanchet A; Goldner M Antonie Van Leeuwenhoek; 1995; 67(3):281-8. PubMed ID: 7778896 [TBL] [Abstract][Full Text] [Related]
5. A surface polysaccharide forms when gonococci are converted to serum resistance by cytidine 5'-monophospho-N-acetyl neuraminic acid. Fox AJ; Curry A; Rowland PL; Lancaster S; Jones DM; Parsons NJ; Cole JA; Smith H FEMS Microbiol Lett; 1990 Jan; 54(1-3):75-80. PubMed ID: 2108900 [TBL] [Abstract][Full Text] [Related]
6. A serum-sensitive, sialyltransferase-deficient mutant of Neisseria gonorrhoeae defective in conversion to serum resistance by CMP-NANA or blood cell extracts. Bramley J; Demarco de Hormaeche R; Constantinidou C; Nassif X; Parsons N; Jones P; Smith H; Cole J Microb Pathog; 1995 Mar; 18(3):187-95. PubMed ID: 7565013 [TBL] [Abstract][Full Text] [Related]
7. The surface structure seen on gonococci after treatment with CMP-NANA is due to sialylation of surface lipopolysaccharide previously described as a 'capsule'. Fox AJ; Curry A; Jones DM; Demarco de Hormaeche R; Parsons NJ; Cole JA; Smith H Microb Pathog; 1991 Sep; 11(3):199-210. PubMed ID: 1724790 [TBL] [Abstract][Full Text] [Related]
8. Effect of sialylation of lipopolysaccharide of Neisseria gonorrhoeae on recognition and complement-mediated killing by monoclonal antibodies directed against different outer-membrane antigens. de la Paz H; Cooke SJ; Heckels JE Microbiology (Reading); 1995 Apr; 141 ( Pt 4)():913-20. PubMed ID: 7539687 [TBL] [Abstract][Full Text] [Related]
9. Interaction of pathogenic Neisseria with host defenses. What happens in vivo? Rest RF; Liu J; Talukdar R; Frangipane JV; Simon D Ann N Y Acad Sci; 1994 Aug; 730():182-96. PubMed ID: 8080170 [TBL] [Abstract][Full Text] [Related]
10. Cytidine 5'-monophospho-N-acetyl neuraminic acid and a low molecular weight factor from human blood cells induce lipopolysaccharide alteration in gonococci when conferring resistance to killing by human serum. Parsons NJ; Patel PV; Tan EL; Andrade JR; Nairn CA; Goldner M; Cole JA; Smith H Microb Pathog; 1988 Oct; 5(4):303-9. PubMed ID: 3148816 [TBL] [Abstract][Full Text] [Related]
11. Resistance to human serum of gonococci in urethral exudates is reduced by neuraminidase. Parsons NJ; Cole JA; Smith H Proc Biol Sci; 1990 Jul; 241(1300):3-5. PubMed ID: 1978333 [TBL] [Abstract][Full Text] [Related]
12. Lactate enhancement of sialylation of gonococcal lipopolysaccharide and of induction of serum resistance by CMP-NANA is not due to direct activation of the sialyltransferase: metabolic events are involved. Parsons NJ; Emond JP; Goldner M; Bramley J; Crooke H; Cole JA; Smith H Microb Pathog; 1996 Sep; 21(3):193-204. PubMed ID: 8878016 [TBL] [Abstract][Full Text] [Related]
13. The serum resistance of gonococci in the majority of urethral exudates is due to sialylated lipopolysaccharide seen as a surface coat. Parsons NJ; Curry A; Fox AJ; Jones DM; Cole JA; Smith H FEMS Microbiol Lett; 1992 Jan; 69(3):295-9. PubMed ID: 1372874 [TBL] [Abstract][Full Text] [Related]
14. Cytidine 5'-monophospho-N-acetylneuraminic acid or a related compound is the low Mr factor from human red blood cells which induces gonococcal resistance to killing by human serum. Nairn CA; Cole JA; Patel PV; Parsons NJ; Fox JE; Smith H J Gen Microbiol; 1988 Dec; 134(12):3295-306. PubMed ID: 3151997 [TBL] [Abstract][Full Text] [Related]
15. Sialylation of lipopolysaccharide by CMP-NANA in viable gonococci is enhanced by low Mr material released from blood cell extracts but not by some UDP sugars. Parsons NJ; Constantinidou C; Cole JA; Smith H Microb Pathog; 1994 Jun; 16(6):413-21. PubMed ID: 7830528 [TBL] [Abstract][Full Text] [Related]
16. Growth of Neisseria gonorrhoeae in CMP-N-acetylneuraminic acid inhibits nonopsonic (opacity-associated outer membrane protein-mediated) interactions with human neutrophils. Rest RF; Frangipane JV Infect Immun; 1992 Mar; 60(3):989-97. PubMed ID: 1541573 [TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation. Mandrell RE; Lesse AJ; Sugai JV; Shero M; Griffiss JM; Cole JA; Parsons NJ; Smith H; Morse SA; Apicella MA J Exp Med; 1990 May; 171(5):1649-64. PubMed ID: 1692081 [TBL] [Abstract][Full Text] [Related]
18. A high Mr factor in human blood which confers serum resistance on gonococci: some properties and synergism with CMP-NANA. Constantinidou C; Beadle D; Zhou XH; Parsons NJ; Sammons CC; Cole JA; Smith H Microb Pathog; 1992 Jun; 12(6):421-32. PubMed ID: 1522797 [TBL] [Abstract][Full Text] [Related]
19. Alterations of the LPS determine virulence of Neisseria gonorrhoeae in guinea-pig subcutaneous chambers. Demarco de Hormaeche R; Macpherson A; Bowe F; Hormaeche CE Microb Pathog; 1991 Sep; 11(3):159-70. PubMed ID: 1800889 [TBL] [Abstract][Full Text] [Related]
20. Neisseria gonorrhoeae strain MS11 harbouring a mutation in gene aroA is attenuated and immunogenic. Chamberlain LM; Strugnell R; Dougan G; Hormaeche CE; Demarco de Hormaeche R Microb Pathog; 1993 Jul; 15(1):51-63. PubMed ID: 8412627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]